Is there a benefit to the lowest possible CA-125: The relationship between biomarkers and survival in epithelial ovarian cancer

被引：1
|
作者：
Clark, M. [1 ]
Al Houssan, L. [2 ]
Liu, Z. [3 ]
Bernardini, M. Q. [3 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Royal Coll Surgeons Ireland, Dublin, Ireland
[3] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON, Canada
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2457
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [31] Relationship between Ca-125 serum levels and FDG PET-CT in recurrent ovarian cancer
    Palomar Munoz, A.
    Cordero Garcia, J.
    Gomez Lopez, O.
    Garcia Vicente, A.
    Gimenez Londono, G.
    Soriano Castrejon, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S473 - S473
  • [32] THE PROGNOSTIC VALUE OF POST CHEMOTHERAPY SERUM CA-125 IN EPITHELIAL OVARIAN-CANCER
    TEELING, M
    MCGING, P
    CARNEY, DN
    IRISH JOURNAL OF MEDICAL SCIENCE, 1989, 158 (03) : 59 - 62
  • [33] Nadir CA-125 Level Is an Independent Prognostic Factor in Advanced Epithelial Ovarian Cancer
    Kang, Sokbom
    Seo, Sang-Soo
    Park, Sang-Yoon
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (03) : 244 - 247
  • [34] Prognostic role of CA-125 nadir in stage IV epithelial ovarian cancer - In reply
    Winter, William E., III
    Maxwell, G. Larry
    Tian, Chunqiao
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1772 - 1772
  • [35] Serum mitochondrial DNA shows a greater effect size than CA-125 in predicting survival in epithelial ovarian cancer
    Grzankowski, K. S.
    Khan, N.
    Kolomeyevskaya, N. V.
    Moysich, K. M.
    Eng, K.
    Lele, S. B.
    Odunsi, K. O.
    Segal, B. H.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 13 - 14
  • [36] Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer
    Lee, Juhun
    Kim, Jong Mi
    Lee, Yoon Hee
    Chong, Gun Oh
    Hong, Dae Gy
    ANTICANCER RESEARCH, 2022, 42 (01) : 349 - 353
  • [37] IS CA-125 MONITORING USEFUL IN PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA AND PREOPERATIVE NEGATIVE CA-125 SERUM LEVELS
    SEVELDA, P
    ROSEN, A
    DENISON, U
    BARRADA, M
    SPONA, J
    SALZER, H
    GYNECOLOGIC ONCOLOGY, 1991, 43 (02) : 154 - 158
  • [38] Novel fluoroimmunoassay for ovarian cancer biomarker CA-125
    Davin Sok
    Lisa-Jo A. Clarizia
    Leslie R. Farris
    Melisenda J. McDonald
    Analytical and Bioanalytical Chemistry, 2009, 393
  • [39] Normal CA-125 and the risk of progression in ovarian cancer
    Markman, Maurie
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (20) : 3310 - 3310
  • [40] The Importance of the CA-125 Value in Patients with Ovarian cancer
    Bachmann, C.
    Bachmann, S.
    Grischke, E. M.
    Fehm, T.
    Wallwiener, D.
    Staebler, A.
    Solomayer, E. F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 733 - 733
12345